Silexion Therapeutics announces pricing of $6M public offering

* Silexion Therapeutics (NASDAQ:SLXN [https://seekingalpha.com/symbol/SLXN]) announced on Thursday the pricing of a public offering [https://seekingalpha.com/pr/20229670-silexion-therapeutics-announces-pricing-of-6_0-million-public-offering] of an aggregate of 1.5M of the company’s ordinary shares, series A warrants, and series B warrants at a combined public offering price of $4.00 per share and accompanying warrants. 
* The gross proceeds from the offering are expected to be $6M. 
* The company intends to use the net proceeds from this offering to advance the company's pre-clinical studies and for general corporate purposes.
* Silexion Therapeutics (NASDAQ:SLXN [https://seekingalpha.com/symbol/SLXN]) shares were up more than 30%. 

 

MORE ON SILEXION THERAPEUTICS

* Seeking Alpha’s Quant Rating on Silexion Therapeutics [https://seekingalpha.com/symbol/SLXN/ratings/quant-ratings]
* Historical earnings data for Silexion Therapeutics [https://seekingalpha.com/symbol/SLXN/earnings]
* Financial information for Silexion Therapeutics [https://seekingalpha.com/symbol/SLXN/income-statement]